Your browser doesn't support javascript.
loading
A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease.
Warren, L; Gibson, R; Ishihara, L; Elango, R; Xue, Z; Akkari, A; Ragone, L; Pahwa, Rajesh; Jankovic, Joseph; Nance, Martha; Freeman, Alan; Watts, Ray L; Hentati, F.
Affiliation
  • Warren L; Research and Development, GlaxoSmithKline Pharmaceuticals, Research Triangle Park, NC 27709, USA. liling.warren@gsk.com
Parkinsonism Relat Disord ; 14(1): 77-80, 2008.
Article in En | MEDLINE | ID: mdl-17433753
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Haplotypes / Protein Serine-Threonine Kinases / Founder Effect Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa / America do norte / Asia / Europa Language: En Journal: Parkinsonism Relat Disord Journal subject: NEUROLOGIA Year: 2008 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Haplotypes / Protein Serine-Threonine Kinases / Founder Effect Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa / America do norte / Asia / Europa Language: En Journal: Parkinsonism Relat Disord Journal subject: NEUROLOGIA Year: 2008 Document type: Article Affiliation country: Country of publication: